Effectiveness of Preoperative Vaginal Cleansing with Povidone-Iodine in Post-ceasarean Infectious Morbidity; A Randomized Controlled Trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201709002597110

Enrollment

180

Registered

2017-09-08

Start date

2017-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth Surgery Post-operative caesarean infectious morbidity

Interventions

preoperative vaginal cleansing with povidone-iodine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All consenting parturients admitted in FETHA for either elective or emergency caesarean section after 37 completed weeks.

Exclusion criteria

Exclusion criteria: Refusal of consent. Women with known allergy to topical povidone-iodine Placenta praevia. Cord prolapse Clinical Chorioamnionitis Foul smelling discharge on admission. Women with immunosupression due to HIV/AIDS, Diabetes Miletus or chronic use of steroids.

Design outcomes

Primary

Measure	Time frame
post caesarean endometritis	—

Secondary

Measure	Time frame
¿ post caesarean wound infection ¿ Post operative fever ¿ Wound breakdown. ¿ Duration of hospitalization.	—

Countries

Nigeria

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026